Viyash Scientific Allots 6.12 Lakh Equity Shares Under ESOP Plans
Viyash Scientific allotted 6,12,773 equity shares under ESOP 2020 and ESOP 2026. 2,30,001 shares were issued at ₹86 and 3,82,772 shares at ₹101. This increases the company's issued and paid-up capital to ₹88,10,40,722.
The allotment of shares under ESOP is a standard practice and has a minimal impact on the overall financial health and market performance of a large listed company.
The announcement is a routine allotment of shares under employee stock option plans and does not significantly impact the company's financial performance or strategic direction.
Viyash Scientific Limited (formerly Sequent Scientific Limited) announced the allotment of 6,12,773 equity shares of face value ₹2 each, fully paid up. This allotment is pursuant to the exercise of stock options under the Sequent Scientific Limited Employee Stock Option Plan 2020 and the Viyash Scientific Limited Employee Stock Option Scheme 2026.
Specifically, 2,30,001 equity shares were allotted at an exercise price of ₹86 per share under Sequent ESOP 2020. Additionally, 3,82,772 equity shares were allotted at an exercise price of ₹101 per share under Viyash ESOP 2026. These new shares will rank pari passu with the existing equity shares of the company.
As a consequence of this allotment, the company's issued and paid-up equity share capital has increased from ₹87,98,15,176 (43,99,07,588 equity shares of ₹2 each) to ₹88,10,40,722 (44,05,20,361 Equity Shares of ₹2 each).
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.